EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy -
JG Paez, PA Janne, JC Lee, S Tracy, H Greulich, S … - Science, 2004 - sciencemag.org
... and geographic groups and argue for the benefit of population ... in Angiogenic Growth
Factor Levels After Gefitinib Treatment in Non-small Cell Lung Cancer. ...
Revisions in the International System for Staging Lung Cancer -
CF Mountain - Chest, 1997 - Am Coll Chest Phys
... C. Doddoli, S. Antoniotti, P. Thomas, and P. Auquier The Place of Patient Satisfaction
in Quality Assessment of Lung Cancer Thoracic Surgery Chest, November 1 ...
Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? -
R Grilli, AD Oxman, JA Julian - Journal of Clinical Oncology, 1993 - jco.ascopubs.org
... Soria, T. Le Chevalier, and JP Pignon Benefits of Adding ... and R. Rosell Chemotherapy
plus Surgery versus Surgery Alone in Non-Small-Cell Lung Cancer N. Engl. ...
… Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With … -
FA Shepherd, J Dancey, R Ramlau, K Mattson, R … - Journal of Clinical Oncology, 2000 - jco.ascopubs.org
... Because the benefits of first-line chemotherapy for ... administration of second-line
treatment deserves careful ... chemotherapy for early-stage lung cancer, and they ...
… (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the … -
M Saunders, S Dische, A Barrett, A Harvey, G … - Radiotherapy and Oncology, 1999 - Elsevier
... monitoring of an area of lung given radical ... Nevertheless, differences between treatment
arms was observed in ... of all patients and those with squamous cancer. ...
… After Gefitinib Treatment in Patients With Non-Small-Cell Lung Cancer With Postoperative Recurrence -
T Mitsudomi, T Kosaka, H Endoh, Y Horio, T Hida, S … - Journal of Clinical Oncology, 2005 - jco.ascopubs.org
... a good predictor of clinical benefit of gefitinib in ... Molecular Analysis of Lung Cancer
Specimens After we ... samples were collected during surgery, rapidly frozen ...
… of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003 -
DG Pfister, DH Johnson, CG Azzoli, W Sause, TJ … - Journal of Clinical Oncology, 2004 - jcojournal.org
... included in the Non-Small Cell Lung Cancer Collaborative Group ... analysis, and the
lack of benefit seen in ... Treatment protocols tested in recent years have used ...
… Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer -
M Fukuoka, S Yano, G Giaccone, T Tamura, K … - Journal of Clinical Oncology, 2003 - jco.ascopubs.org
... chemotherapy, quality of life benefits and survival ... practice guidelines for the
treatment of unresectable non- small-cell lung cancer: Adopted on ...
… Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid … -
LS Rosen, D Gordon, S Tchekmedyian, R Yanagihara, … - Journal of Clinical Oncology, 2003 - jcojournal.org
... This is the first large randomized trial to demonstrate a treatment benefit for
bisphosphonate therapy in patients with lung cancer and other solid tumors. ...
… in previously treated patients with refractory advanced non-small-cell lung cancer: results from a …
N Thatcher, A Chang, P Parikh, J Rodrigues Pereira … - The Lancet, 2005 - Elsevier
... accounts for about 80% of all cases of lung cancer. ... survival from the start of last
treatment of 4 ... 6 The small survival benefits obtained with these treatment ...
Source: Google Scholar |